SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 661.74 |
Enterprise Value ($M) | 612.41 |
Book Value ($M) | n/a |
Book Value / Share | 3.09 |
Price / Book | 3.01 |
NCAV ($M) | 188.31 |
NCAV / Share | 2.65 |
Price / NCAV | 3.51 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -0.58 |
Return on Assets (ROA) | -0.38 |
Return on Equity (ROE) | -0.40 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 12.00 |
Current Ratio | 12.00 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 211.43 |
Assets | n/a |
Liabilities | 23.12 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | -142.90 |
Net Income | -127.85 |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | -112.66 |
Cash from Investing | 22.14 |
Cash from Financing | 126.55 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13D | Sr One Capital Management, Llc | 5.40 | ||
13G | Point72 Asset Management, L.P. | 5.10 | ||
13G | Venrock Healthcare Capital Partners III, L.P. | 7.70 | 107.28 | |
13G/A | Frazier Life Sciences Public Fund, L.P. | 2.00 | -65.96 | |
13G/A | Viking Global Investors Lp | 9.20 | 64.32 | |
13G/A | Fmr Llc | 3.50 | -43.64 | |
13G/A | Nextech Crossover I GP S.a r.l. | 7.50 | 23.33 | |
13G/A | EcoR1 Capital, LLC | 4.90 | -45.53 | |
13G/A | Column Group Ii, Lp | 5.20 | -0.75 | |
13G/A | Alkeon Capital Management Llc | 5.50 | 8.32 | |
13G | BlackRock, Inc. | 7.20 | 0.00 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
355,801 | 1,281,506 | 27.76 | |
409,117 | 1,365,462 | 29.96 | |
997,648 | 2,022,961 | 49.32 | |
422,074 | 1,069,243 | 39.47 | |
(click for more detail) |
Similar Companies | |
---|---|
OGI – Organigram Global Inc. | OLMA – Olema Pharmaceuticals, Inc. |
OPK – OPKO Health, Inc. | OVID – Ovid Therapeutics Inc. |
PBYI – Puma Biotechnology, Inc. |
Financial data and stock pages provided by
Fintel.io